Role of Intravenous Iron Hydroxide Sucrose in the Management of Iron Deficiency Anemia in Pregnancy

OBJECTIVE: To determine the safety and efficacy of iron hydroxide sucrose complex infusion in the correction of iron deficiency anemia in second and third trimester of pregnancy. STUDY DESIGN: A prospective observational study. th PLACE AND DURATION: One year, from 1st April 2013 to 30 March 2014 at department of Gynae and Obstetrics, Cantonment General Hospital Rawalpindi Pakistan. METHODOLOGY: A total of 122 women were studied. Thirty two (26.2%) women had mild anemia, 74 women ( 59.0% ) had moderate anemia and 16 (13.1%) women had severe anemia .The mean age of women was 26 yrs (range 18-38 years) and the mean gestational age at the of diagnosis was 26.79 ± 4.2 weeks ( range 17-32 week). Six women went into preterm labor and delivered at 33-34 weeks. Four women didn't receive the required iron dosage schedule because of loss of follow up. Time taken to achieve the required hemoglobin level was 4.5 ± 1.3 week. RESULT: Mean hemoglobin was 6-9 gm/dl on which intravenous iron sucrose 6001000 mg was given parenterally in patients with pregnancy related anemia and the average hemoglobin rise was 2.2 gm/dl. CONCLUSION: Iron sucrose complex was effective and safe treatment of pregnancy associated iron deficiency anemia.